Literature DB >> 11302300

Duration of symptoms and outcome of hemiresurfacing for hip osteonecrosis.

P E Beaulé1, T P Schmalzried, P Campbell, F Dorey, H C Amstutz.   

Abstract

Thirty-seven hips with Ficat Stage II, III, or early IV osteonecrosis were treated with hemiresurfacing. The purpose of this study is to analyze specifically the clinical and radiographic results of patients who had hemiresurfacing to refine the indications for the procedure and identify factors substantially affecting clinical outcome and survivorship. At an average followup of 6.5 years, the average University of California Los Angeles hip scores for pain, walking, function, and activity improved significantly from 4.3, 6.0, 5.3, and 4.2 to 8.0, 8.8, 7.9, and 5.8. The overall survivorship was 79%, 59%, and 45% at 5, 10, and 15 years. Eleven hips have been converted: 10 hips for acetabular cartilage wear and one hip for femoral loosening. The average time to conversion was 7.5 years. A longer duration of symptoms before surgery (16.6 months versus 12.1 months) was associated with a worse acetabular cartilage grading and suggested a relationship with a shorter time to conversion, although the difference was not statistically significant at the 5% level. Survivorship is better when preoperative symptoms are present for 1 year or less, possibly because the articular cartilage is healthier. When necessary, conversion to total hip replacement can be done without adverse results.

Entities:  

Mesh:

Year:  2001        PMID: 11302300     DOI: 10.1097/00003086-200104000-00018

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  16 in total

1.  Bone scintigraphy in femoroacetabular impingement: a preliminary report.

Authors:  Wadih Y Matar; Olivier May; François Raymond; Paul E Beaulé
Journal:  Clin Orthop Relat Res       Date:  2008-12-17       Impact factor: 4.176

2.  Surface replacement is comparable to primary total hip arthroplasty.

Authors:  Mike S McGrath; David R Marker; Thorsten M Seyler; Slif D Ulrich; Michael A Mont
Journal:  Clin Orthop Relat Res       Date:  2008-09-16       Impact factor: 4.176

3.  Hip resurfacing results for osteonecrosis are as good as for other etiologies at 2 to 12 years.

Authors:  Harlan C Amstutz; Michel J Le Duff
Journal:  Clin Orthop Relat Res       Date:  2009-09-12       Impact factor: 4.176

Review 4.  Current concepts on osteonecrosis of the femoral head.

Authors:  Joaquin Moya-Angeler; Arianna L Gianakos; Jordan C Villa; Amelia Ni; Joseph M Lane
Journal:  World J Orthop       Date:  2015-09-18

Review 5.  [Surgical treatment concepts for femoral head necrosis].

Authors:  D von Stechow; P Drees
Journal:  Orthopade       Date:  2007-05       Impact factor: 1.087

6.  SAS weekly rounds: avascular necrosis.

Authors:  Thomas W Hamilton; Susan M Goodman; Mark Figgie
Journal:  HSS J       Date:  2009-03-18

7.  Femoral resurfacing in young patients with hematologic cancer and osteonecrosis.

Authors:  Evguenia J Karimova; Shesh N Rai; Jianrong Wu; Lunetha Britton; Sue C Kaste; Michael D Neel
Journal:  Clin Orthop Relat Res       Date:  2008-08-05       Impact factor: 4.176

Review 8.  [Resurfacing for osteonecrosis of the femoral head].

Authors:  M Akbar; M A Mont; C Heisel; D R Marker; S D Ulrich; T M Seyler
Journal:  Orthopade       Date:  2008-07       Impact factor: 1.087

Review 9.  Is patient selection important for hip resurfacing?

Authors:  Ryan M Nunley; Craig J Della Valle; Robert L Barrack
Journal:  Clin Orthop Relat Res       Date:  2008-10-22       Impact factor: 4.176

10.  Survivorship of monoblock trabecular metal cups in primary THA : midterm results.

Authors:  Konstantinos N Malizos; Konstantinos Bargiotas; Loukia Papatheodorou; Michael Hantes; Theofilos Karachalios
Journal:  Clin Orthop Relat Res       Date:  2008-01-03       Impact factor: 4.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.